Manufacturing

Vaccine production using cell culture technology

Nobilon’s modern multi-purpose facility for vaccine production is based on fermentor technology (cell culture) with the advantage that it is a serum- and animal component free production process.

This innovative technique for producing viral vaccines, uses mammalian cells from a tested cell bank, instead of fertilized chicken eggs which are used nowadays. It is a modern technique that ensures products of high quality and purity.

Independence from the supply of fertilized eggs also means that production of viral vaccines can be initiated much faster.

Down-stream processing, including purification and inactivation (if applicable) of bulk antigens completes the production process.

Nobilon’s production facility can be used to make viral and bacterial vaccines and monoclonal antibodies (MAB's).